# Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer

> **NCT00202969** · PHASE3 · COMPLETED · sponsor: **Taiho Pharmaceutical Co., Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** S-1
- **DRUG:** S-1 plus CDDP
- **DRUG:** 5-FU plus CDDP

## Key facts

- **NCT ID:** NCT00202969
- **Lead sponsor:** Taiho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2007-01
- **Final completion:** 2007-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2011-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00202969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00202969, "Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00202969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*